Citations

Showing 10 of 108094 citations.

Musculoskeletal coccidioidomycosis
Belthur, Mohan V. , Blair, Janis E. , Shrader, M. Wade , Malone, Jason

Mayo Clinic

Current Orthopaedic Practice | June 27, 2018 | Volume: 29 | Issue: 4 | Pages: 400-406

10.1097/bco.0000000000000652 Get It

Coccidioidomycosis is an invasive fungal infection caused by the inhalation of aerosolized spores of Coccidioides spp., which reside in the arid soil of the southwestern United States and northern Mexico. The primary infection occurs in the lungs; however, less than 40% of patients are symptomatic. Dissemination of coccidioidomycosis is rare (1-5%), but can lead to extra pulmonic disease involving any organ. Skeletal coccidioidomycosis occurs in 10% to 50% of disseminated infections. Skeletal coccidioidomycosis is a chronic and progressive infection that eventually results in bone destruction and loss of function and often involves adjacent structures such as joints, muscles, tendons and other soft tissues. This infection is frequently multifocal with axial skeletal involvement. Although radiographs and other imaging methods identify relevant abnormalities, histopathologic examination with culture of the involved bone is the only means to confirm the diagnosis. Serologic testing is adjunctive, and complement fixation titers can be evaluated serially to assess response to treatment. Skeletal coccidioidomycosis is difficult to treat, and a combination of medical therapy and surgical debridement often is needed. Early diagnosis and treatment are critical to avoid long-term problems.
History of the World Society for Pediatric and Congenital Heart Surgery: The First Decade
Tchervenkov, Christo I., Kurosawa, Hiromi, Mavroudis, Constantine , Jatene, Marcelo Biscegli , Al‐Halees, Zohair , Çïçek, Sertaç , Sandoval, Néstor , Backer, Carl L., Cervantes, Jorge , Edwin, Frank , Finucane, Kirsten , Iyer, Krishna, Kinsley, Robin H. , Kreutzer, Christián , Liu, Jinfen , Maruszewski, Bohdan , Sarris, George E. , Jonas, Richard A. , Çiçek, Sertaç M, Jacobs, Jeffrey P. , Stellin, Giovanni , Dearani, Joseph A. , Ebels, Tjark , Fragata, José , Kirklin, James K. , Louis, James D. St.

Mayo Clinic

World Journal for Pediatric and Congenital Heart Surgery | June 26, 2018 | Volume: 9 | Issue: 4 | Pages: 392-406

10.1177/2150135118775962 | PMID 29945512 Get It

The World Society for Pediatric and Congenital Heart Surgery (WSPCHS) is the largest professional organization in the world dedicated to pediatric and congenital heart surgery. The purpose of this article is to document the first decade of the history of WSPCHS from its formation in 2006, to summarize the current status of WSPCHS, and to consider the future of WSPCHS. The WSPCHS was incorporated in Canada on April 7, 2011, with a head office in Montreal, Canada. The vision of the WSPCHS is that every child born anywhere in the world with a congenital heart defect should have access to appropriate medical and surgical care. The mission of the WSPCHS is to promote the highest quality comprehensive cardiac care to all patients with congenital heart disease, from the fetus to the adult, regardless of the patient’s economic means, with an emphasis on excellence in teaching, research, and community service.
A Letter to the Resident Starting My Service…
Dearani, Joseph A. , Dearani, Joseph A.

Mayo Clinic

World Journal for Pediatric and Congenital Heart Surgery | June 26, 2018 | Volume: 9 | Issue: 4 | Pages: 381-382

10.1177/2150135118775384 | PMID 29945511 Get It

Revisional and Reconstructive Surgery for Failing IPAA is Associated with Good Function and Pouch Salvage in Highly Selected Patients
Shogan, Benjamin D. , Mathis, Kellie L. , Duchalais, Émilie , Pembérton, John H., Dozois, Eric J. , Lightner, Amy L. , Larson, David W.

Mayo Clinic

Diseases of the Colon & Rectum | June 26, 2018 | Volume: 61 | Issue: 8 | Pages: 920-930

10.1097/dcr.0000000000001130 | PMID 29944583 Get It

BACKGROUND: Revisional and reconstructive surgery for IPAA is rare given the high success of pouch surgery for chronic ulcerative colitis. Limited data exist on both surgical and functional outcomes in patients with chronic ulcerative colitis who undergo IPAA revision or reconstruction. OBJECTIVE: This study aimed to determine the surgical and functional outcome in patients with chronic ulcerative colitis who undergo IPAA revision or reconstruction. DESIGN: A prospectively collected surgical database was accessed for this study. SETTING: This study was conducted at an IBD referral center. PATIENTS: Patients with chronic ulcerative colitis who underwent IPAA revision or reconstruction were selected. MAIN OUTCOME MEASURES: The primary outcomes measured were 30-day postoperative outcomes and long-term pouch function. RESULTS: Eighty-one patients were identified. Original IPAA was performed for chronic ulcerative colitis (n = 71; 88%) and indeterminate colitis (n = 11; 12.%), and the most common configuration was a J-pouch (n = 69; 86%) with handsewn anastomosis (n = 41;68%). No independent predictors of 30-day postoperative complications following reconstructive/revisional surgery were identified. Pelvic abscesses and Crohn’s disease of the pouch were independently associated with ultimate pouch excision. Median follow-up following revision/reconstruction was 40 months (range, 1–292 months) during which 15 patients (23%) had pouch failure. The 5- and 10-year pouch survival rates following revision were 85 ± 5% and 65 ± 9% by Kaplan-Meier estimation; age <30 years was significantly associated with pouch survival. Long-term function (n = 30; 35%) compared with a matched control cohort of primary IPAA was characterized by significantly increased daytime bowel incontinence (p = 0.0119), liquid stool (p = 0.0062), and medication to thicken stools (p = 0.0452). LIMITATIONS: This was a single-center series, and response rate for functional data was 35%. CONCLUSIONS: In properly selected patients with a failing pouch, originally made for chronic ulcerative colitis or indeterminate colitis, revisional and reconstructive surgery is associated with low complication rates, high pouch salvage, and acceptable long-term pouch function. See Video Abstract at http://links.lww.com/DCR/A640.
Cell-Based Therapies in Vascularized Composite Allotransplantation
Mohan, Anita T. , Tran, Duy , Mardini, Samir , Vyas, Krishna S. , Morrison, Shane D.

Mayo Clinic

Journal of Reconstructive Microsurgery | June 26, 2018 | Volume: 34 | Issue: 08 | Pages: 642-650

10.1055/s-0038-1661336 | PMID 29945289 Get It

Background Dendritic cells (DCs) are bone marrow-derived, professional antigen-presenting cells with tolerogenic function. The ability of DCs to regulate alloantigen-specific T cell responses and to promote tolerance has aligned them ideally for a role in vascularized composite allotransplantation (VCA). In this study, we summarize the current evidence for DC therapies for tolerance induction to alleviate the requirement for chronic immunosuppression. Method A comprehensive and structured review of manuscripts published on VCA was performed using the MEDLINE and PubMed databases. All eligible studies published from the year 2000 to 2017 were included in the final results. Result Nineteen original preclinical and clinical studies that employed cell therapy for VCA were included in this review. In vivo DC therapy was found to direct the alloimmune response toward either transplant rejection or tolerance in VCA models. While injection of mature DCs rapidly increases T-cell activity in humans and promotes transplant rejection, the injection of immature DCs acts as an immunosuppressant and inhibits T-cell activity. In addition to immature DCs, mesenchymal stem cells were also found to have a positive effect on allotransplantation of solid organs and bone marrow via cytokine expression which decreases the alloreactive effector lymphocytes and increases CD4+/CD25+/FoxP3 Tregs. Despite the promising findings, the efficacy of cell-based therapies varies greatly across studies, partly due to different methods of cell isolation and purification techniques, source, route and timing of administration, and combination immunosuppressive therapy. Conclusion Additional research is needed to evaluate the efficacy and safety of DC and other cell-based therapeutic measures in human allotransplant recipients. Future direction will focus on the development of novel methods to reduce immunosuppression and develop more individualized management, as well as the clinical application of basic research in the mechanisms of immunologic tolerance.
Pump Position Impacts HeartMate II Left Ventricular Assist Device Thrombosis
Ransom, John , Maltais, Simon, Sun, Benjamin , Entwistle, John W. , Bailey, Stephen, John, Ranjit , Klodell, C.T., Gregorič, Igor D. , Sheridan, Brett C. , Chuang, Joyce, Farrar, David J. , Sundareswaran, Kartik S., Adamson, Robert, Kılıç, Ahmet

Mayo Clinic

ASAIO Journal | June 26, 2018 | Volume: 65 | Issue: 3 | Pages: 227-232

10.1097/mat.0000000000000840 | PMID 29952801 Get It

The PREVENtion of HeartMate II pump Thrombosis through clinical management (PREVENT) study was a multicenter, prospective investigation to evaluate the rate of pump thrombosis (PT) with adoption of a uniform set of surgical and medical practices for left ventricular assist device implantation. We sought to quantify pump position at baseline and retrospectively define a pump position associated with poor clinical outcomes. Chest x-rays at baseline were prospectively obtained per protocol. Pump pocket depth, inflow cannula (IC) angle relative to the pump, and IC angle relative to the vertical were measured. Pumps falling in the tail-ends of the IC angle and pump pocket depth distributions were categorized as having an extreme pump position within the PREVENT study. Patients with extreme pump position had a significantly higher risk of confirmed and suspected PT, hemolysis, and elevated lactate dehydrogenase. In a multivariable analysis of survival free of confirmed PT, extreme pump position was an independent risk factor (hazard ratio = 3.6; 95% confidence interval = 1.5–8.9; p = 0.006) when adjusting for differences in pump speed and anticoagulation level. Our analysis shows that HeartMate II pump position at implant can significantly impact event-free survival and the incidence of adverse events at 6 months.
Total Wrist Arthroplasty
Srnec, Jason J. , Wagner, Eric R. , Rizzo, Marco , Wagner, Eric R

Mayo Clinic

JBJS Reviews | June 26, 2018 | Volume: 6 | Issue: 6 | Pages: e9-e9

10.2106/jbjs.rvw.17.00123 | PMID 29944487 Get It

* There are limited motion-sparing salvage options for patients with pancarpal wrist arthritis. Total wrist arthroplasty is one option that has long been used in an attempt to preserve motion while relieving pain and wrist dysfunction; however, enthusiasm for the procedure has been tempered by high rates of complications. * In an attempt to minimize or eliminate these complications, recent implants have been redesigned with a more semiconstrained arc of motion and ellipsoidal articulation. Furthermore, the distal component has undergone many different modifications to improve bone growth into the implant. * Short-term small series have shown promising improvements in terms of the rate of complications as compared with previous-generation designs.
Total Hip Arthroplasty in a Patient with Camurati-Engelmann Disease
Ge, David H. , Yu, Stephen , Ziegler, Jacob D. , Schwarzkopf, Ran

Mayo Clinic

JBJS Case Connector | June 26, 2018 | Volume: 8 | Issue: 2 | Pages: e45-e45

10.2106/jbjs.cc.17.00286 | PMID 29952779 Get It

Case: We review the case of a 44-year-old man with Camurati-Engelmann disease, who presented with chronic right hip pain that did not improve following intra-articular hip injections. He was functionally debilitated because of the worsening pain. Routine radiographs demonstrated severe right hip osteoarthritis and severe diaphyseal sclerosis of the femur. To address the narrowed medullary cavity, appropriate reaming of the diaphysis and broaching to fill the metaphysis were performed. The patient underwent an uncemented total hip arthroplasty that resulted in an excellent recovery with no complications. Conclusion: Uncemented total hip arthroplasty serves as a good option for patients with hip osteoarthritis secondary to Camurati-Engelmann disease. Anticipation of potential operative challenges is the key to avoiding complications and achieving an optimal, durable outcome.
Incidence and Epidemiology of Perioperative Transfusion-Related Pulmonary Complications in Pediatric Noncardiac Surgical Patients: A Single-Center, 5-Year Experience
Thalji, Leanne, Thum, Daniel E., Weister, Timothy J. , Weber, Wayne V., Stubbs, James R. , Kor, Daryl J. , Nemergut, Michael E.

Mayo Clinic

Anesthesia & Analgesia | June 26, 2018 | Volume: 127 | Issue: 5 | Pages: 1180-1188

10.1213/ane.0000000000003574 | PMID 29944520 Get It

BACKGROUND: Transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO) are the leading causes of transfusion-related fatalities. While these transfusion-related pulmonary complications (TRPCs) have been well detailed in adults, their burden in pediatric subsets remains poorly defined. We sought to delineate the incidence and epidemiology of pediatric TRPCs after intraoperative blood product transfusion. METHODS: In this retrospective cohort study, we evaluated all consecutive pediatric patients receiving intraoperative blood product transfusions during noncardiac surgeries between January 2010 and December 2014. Exclusion criteria were cyanotic heart disease, preoperative respiratory insufficiency, extracorporeal membrane oxygenation, and American Society of Anesthesiologists physical status VI. Medical records were electronically screened to identify those with evidence of hypoxemia, and in whom a chest x-ray was obtained within 24 hours of surgery. Records were then manually reviewed by 2 physicians to determine whether they met diagnostic criteria for TACO or TRALI. Disagreements were adjudicated by a third senior physician. RESULTS: Of 19,288 unique pediatric surgical patients, 411 were eligible for inclusion. The incidence of TRPCs was 3.6% (95% confidence interval [CI], 2.2–5.9). TACO occurred in 3.4% (95% CI, 2.0–5.6) of patients, TRALI was identified in 1.2% (95% CI, 0.5–2.8), and 1.0% (95% CI, 0.4–2.5) had evidence for both TRALI and TACO. Incidence was not different between males (3.4%) and females (3.8%; P = .815). Although a trend toward an increased incidence of TRPCs was observed in younger patients, this did not reach statistical significance ( P = .109). Incidence was comparable across subsets of transfusion volume ( P = .184) and surgical specialties ( P = .088). Among the 15 patients experiencing TRPCs, red blood cells were administered to 13 subjects, plasma to 3, platelets to 3, cryoprecipitate to 2, and autologous blood to 3. Three patients with TRCPs were transfused mixed blood components. CONCLUSIONS: TRPCs occurred in 3.6% of transfused pediatric surgical patients, with the majority of cases attributable to TACO, congruent with adult literature. The frequency of TRPCs was comparable between genders and across surgical procedures and transfusion volumes. The observed trend toward increased TRPCs in younger children warrants further consideration in future investigations. Red blood cell administration was the associated component for the majority of TRPCs, although platelets demonstrated the highest risk per component transfused. Mitigation of perioperative risk associated with TRPCs in pediatric patients is reliant on further multiinstitutional studies powered to examine patterns and predictors of this highly morbid entity.
Scapular muscle balance and spinal stabilizer recruitment during an inverted row
Youdas, James W., Hubble, Justin W., Johnson, Peter , McCarthy, Megan M., Saenz, Michelle M., Hollman, John H. , Johnson, Peter G, Hollman, John

Mayo Clinic

Physiotherapy Theory and Practice | June 26, 2018 | Volume: 36 | Issue: 3 | Pages: 432-443

10.1080/09593985.2018.1486491 | PMID 29944029 Get It